Cite
HARVARD Citation
Macaluso, F. et al. (2020). A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis. Digestive and liver disease. 52 (12), pp. 1461-1466. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Macaluso, F. et al. (2020). A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis. Digestive and liver disease. 52 (12), pp. 1461-1466. [Online].